These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2345 related articles for article (PubMed ID: 8050828)
21. Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats. Aparicio T; Kermorgant S; Dessirier V; Lewin MJ; Lehy T Carcinogenesis; 1999 Aug; 20(8):1445-51. PubMed ID: 10426790 [TBL] [Abstract][Full Text] [Related]
22. Effect of the metalloproteinase inhibitor batimastat in the systemic toxicity induced by Bothrops asper snake venom: understanding the role of metalloproteinases in envenomation. Rucavado A; Escalante T; Gutiérrez JM Toxicon; 2004 Mar; 43(4):417-24. PubMed ID: 15051405 [TBL] [Abstract][Full Text] [Related]
23. Augmented growth inhibition of B16-BL6 melanoma by combined treatment with a selective matrix metalloproteinase inhibitor, MMI-166, and cytotoxic agents. Hojo K; Maki H; Sawada TY; Maekawa R; Yoshioka T Anticancer Res; 2002; 22(6A):3253-9. PubMed ID: 12530072 [TBL] [Abstract][Full Text] [Related]
24. A clinically relevant, syngeneic model of spontaneous, highly metastatic B16 mouse melanoma. Bobek V; Kolostova K; Pinterova D; Kacprzak G; Adamiak J; Kolodziej J; Boubelik M; Kubecova M; Hoffman RM Anticancer Res; 2010 Dec; 30(12):4799-803. PubMed ID: 21187455 [TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase inhibitor, MMI270 (CGS27023A) inhibited hematogenic metastasis of B16 melanoma cells in both experimental and spontaneous metastasis models. Kasaoka T; Nishiyama H; Okada M; Nakajima M Clin Exp Metastasis; 2008; 25(7):827-34. PubMed ID: 18668328 [TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Wang X; Fu X; Brown PD; Crimmin MJ; Hoffman RM Cancer Res; 1994 Sep; 54(17):4726-8. PubMed ID: 8062271 [TBL] [Abstract][Full Text] [Related]
27. Cell membrane signaling as target in cancer therapy. II: Inhibitory effect of N,N,N-trimethylsphingosine on metastatic potential of murine B16 melanoma cell line through blocking of tumor cell-dependent platelet aggregation. Okoshi H; Hakomori S; Nisar M; Zhou QH; Kimura S; Tashiro K; Igarashi Y Cancer Res; 1991 Nov; 51(22):6019-24. PubMed ID: 1657377 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model. Watson SA; Morris TM; Parsons SL; Steele RJ; Brown PD Br J Cancer; 1996 Nov; 74(9):1354-8. PubMed ID: 8912529 [TBL] [Abstract][Full Text] [Related]
29. Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16. Wald M; Olejár T; Sebková V; Zadinová M; Boubelík M; Poucková P Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S16-22. PubMed ID: 11561867 [TBL] [Abstract][Full Text] [Related]
30. Effects of matrix metalloproteinase inhibitor BB-94 on liver cancer growth and metastasis in a patient-like orthotopic model LCI-D20. Bu W; Tang ZY; Sun FX; Ye SL; Liu KD; Xue Q; Chen J; Gao DM Hepatogastroenterology; 1998; 45(22):1056-61. PubMed ID: 9756006 [TBL] [Abstract][Full Text] [Related]
31. Antimetastatic and antitumor effect of a recombinant human tissue inhibitor of metalloproteinases-2 in murine melanoma models. Oku T; Ata N; Yonezawa K; Tokai H; Fujii H; Shinagawa A; Ohuchi E; Saiki I Biol Pharm Bull; 1997 Aug; 20(8):843-9. PubMed ID: 9300128 [TBL] [Abstract][Full Text] [Related]
32. Modulation of B16-BL6 murine melanoma metastatic phenotype by tyrosine and phenylalanine restriction in the absence of host selection pressures. Elstad CA; Meadows GG Anticancer Res; 1993; 13(2):523-8. PubMed ID: 8517667 [TBL] [Abstract][Full Text] [Related]
33. Enhancement of pulmonary metastasis formation and gamma-glutamyltranspeptidase activity in B16 melanoma induced by differentiation in vitro. Prezioso JA; Wang N; Duty L; Bloomer WD; Gorelik E Clin Exp Metastasis; 1993 May; 11(3):263-74. PubMed ID: 8097141 [TBL] [Abstract][Full Text] [Related]
34. Effect of PKC412, a selective inhibitor of protein kinase C, on lung metastasis in mice injected with B16 melanoma cells. Yoshikawa N; Nakamura K; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M Life Sci; 2003 Feb; 72(12):1377-87. PubMed ID: 12527035 [TBL] [Abstract][Full Text] [Related]
35. Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. Khokha R J Natl Cancer Inst; 1994 Feb; 86(4):299-304. PubMed ID: 8158685 [TBL] [Abstract][Full Text] [Related]
36. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo. Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317 [TBL] [Abstract][Full Text] [Related]
37. Effect of PKC412, an inhibitor of protein kinase C, on spontaneous metastatic model mice. Nakamura K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M Anticancer Res; 2003; 23(2B):1395-9. PubMed ID: 12820400 [TBL] [Abstract][Full Text] [Related]
38. Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer. Wojtowicz-Praga S; Low J; Marshall J; Ness E; Dickson R; Barter J; Sale M; McCann P; Moore J; Cole A; Hawkins MJ Invest New Drugs; 1996; 14(2):193-202. PubMed ID: 8913840 [TBL] [Abstract][Full Text] [Related]
39. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth. Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]